Alzheimer’s sufferers in Britain will now get to buy first drug shown to slow disease

2 comments

1. “But it was rejected by the European Medicines Agency in July after the regulator considered its benefits were relatively small and did not outweigh the risk of serious side-effects such as bleeding and swelling in the brain.”

   So there’s that

2. To think we could have had this 15 years ago.
   https://www.science.org/content/article/potential-fabrication-research-images-threatens-key-theory-alzheimers-disease